
Experience
Agtech Startup eFishery Announces Series D Financing, Unicorn Status
July 11, 2023
Cooley advised eFishery, an Indonesia-based agtech startup, on its Series D financing raising $200 million, bringing its valuation to $1.4 billion.
Related contacts
Related Practices & Industries
Structure Therapeutics – $185.3 Million IPO
February 9, 2023
San Francisco – February 9, 2023 – Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.
The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.
Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.
Related contacts
Related Practices & Industries
2C2P and Ant Group Partner to Accelerate Digital Payment Adoption
April 21, 2022
Cooley advised 2C2P, a global payments platform, on its strategic partnership with Ant Group, an innovative technology provider that strives to bring the world inclusive, green and sustainable services. Lawyers Matthew Bartus and Gwenlynne Lee led the Cooley team advising 2C2P.
Related contacts
Related Practices & Industries
Asymchem Agrees to Acquire Snapdragon Chemistry
February 12, 2022
Cooley advised Asymchem, a Chinese-based contract development and manufacturing company serving the global pharmaceutical and biotech industry, on its definitive agreement to acquire Snapdragon Chemistry, a US-based chemical technology company. Partner Yiming Liu led the Cooley team.
As a result of the transaction, Asymchem will significantly expand its footprint in the US, offering customers a seamless path from preclinical process R&D through commercial current good manufacturing practice (cGMP) production. Snapdragon will operate as a stand-alone Asymchem division, and continue with its ongoing lab and manufacturing facility expansion for additional capacity to support larger, pilot-scale manufacturing in Waltham, Massachusetts.
"We believe continuous flow manufacturing is a revolutionary technology and represents the future of pharmaceutical production, not only generating advantages to process safety and cost, but also bringing tremendous environmental benefits," Hao Hong, chairman and CEO of Asymchem, said in a news release. "Asymchem has been deeply committed to flow chemistry technology development and its application expansion in the pharmaceutical industry for more than a decade. We are excited that this strategic acquisition will further strengthen our capabilities in continuous manufacturing, as well as broadening our service scope and client pool."
Related contacts
Related Practices & Industries
Japan’s Paidy Agrees to Sell to PayPal for $2.7 Billion
September 10, 2021
Cooley advised Japanese company Paidy, a two-sided payments platform and provider of buy now, pay later (BNPL) solutions, on its agreement to sell to PayPal for approximately $2.7 billion in cash. Lawyers Rama Padmanabhan, Patrick Loofbourrow, Rowook Park, Andrew Harline and Vivian Tsai led the US- and Asia-based Cooley team advising Paidy on the transaction, which highlights Cooley’s strong capability for executing complex, globally handled deals.